Research programme: anti-inflammatory compounds - Novartis

Drug Profile

Research programme: anti-inflammatory compounds - Novartis

Alternative Names: VAF-347

Latest Information Update: 21 Jul 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Novartis
  • Class Amines; Chlorophenols; Pyrimidines; Small molecules
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Inflammation

Most Recent Events

  • 09 Aug 2006 Preclinical trials in Inflammation in Austria (unspecified route)
  • 09 Aug 2006 Preclinical trials in Inflammation in Switzerland (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top